Clinical Trial: Efficacy of Spinal Cord Stimulation in Chemotherapy-Induced Peripheral Neuropathy

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07579611) titled 'Efficacy of Spinal Cord Stimulation in Chemotherapy-Induced Peripheral Neuropathy' on April 29.

Brief Summary: Chemotherapy-induced peripheral neuropathy (CIPN) is a frequent and debilitating side effect of many cancer treatments. It affects 28 to 48% of patients receiving chemotherapy. Symptoms include tingling, numbness, burning sensations, and pain mainly in the hands and feet. While CIPN often improves after chemotherapy ends, in some patients the pain persists and becomes chronic, severely impairing quality of life, sleep, and daily functioning.

Currently, no treatment has been shown to prevent CIPN. For patients with chronic p...